+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Iron hydroxide polymaltose--cause of persistent iron deficiency anemia at delivery



Iron hydroxide polymaltose--cause of persistent iron deficiency anemia at delivery



Indian Journal of Medical Sciences 55(11): 616-620



Ironhydroxide polymaltose (IPC) preparations were used to treat four pregnant women with iron deficiency anemia. Despite patient compliance for sufficient length of time, hemoglobin failed to rise. By the time this was noticed, pregnancy was well advanced and delivery was only few weeks away. Patients were switched over to ferrous fumarate/succinate/parenteral iron. Although hemoglobin increased, women were still iron deficient at the time of delivery. Besides exposing women to hazards of iron deficiency at the time of delivery, their new borns are exposed to the risks intrauterine growth retardation and its consequences in childhood and later life. It would be advisable to avoid the use IPC preparations in patients with iron deficiency anemia, especially pregnant women.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046471217

Download citation: RISBibTeXText

PMID: 12508635


Related references

Effect of oral aluminium hydroxide on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study. Arzneimittel-Forschung 57(6a): 392-400, 2007

Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy. Journal of the Association of Physicians of India 50: 279-280, 2002

A comparative study of iron salts vs hydroxide polymaltose iron complex efficacy in the treatment of iron deficiency anemia in presenile and senile patients. Gematologiya i Transfuziologiya 49(1): 29-32, January-February, 2004

Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study. Arzneimittel-Forschung 57(6a): 376-384, 2007

Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology 12(3): 255-256, 2007

Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis. Arzneimittel-Forschung 57(6a): 431-438, 2007

Effect of an oral iron(III)-hydroxide polymaltose complex on tetracycline pharmacokinetics in patients with iron deficiency anemia. Arzneimittel-Forschung 57(6a): 385-391, 2007

Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia. International Journal of Pediatrics 2011: 524520, 2011

Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children. International Journal of Clinical Pharmacology and Therapeutics 36(6): 320-325, 1998

Complex of iron hydroxide with polymaltose Efficacy in cases on infantile iron deficiency. Pediatriya (Moscow) (6): 67-72, November-December, 2002

Iron deficiency anemia caused by undernutrition in childhood. Treatment with polymaltose iron. Hospital 77(4): 1369-1374, 1970

Efficacy and safety of intravenous iron polymaltose in the treatment of iron deficiency anemia. Blood 92(10 Suppl. 1 Part 1-2): 24B, 1998

Iron Polymaltose Complex in the Treatment of Iron Deficiency Anemia in Pregnancy. Mymensingh Medical Journal 25(3): 506-513, 2016

Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia. Minerva Pediatrica 71(5): 449-454, 2019

Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy. Journal of Pediatric Hematology/Oncology 32(8): 585-588, 2010